Detalles de la búsqueda
1.
Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib-Treated Cancer.
CPT Pharmacometrics Syst Pharmacol
; 6(9): 604-613, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28571114
2.
Biomarker response on exposure to sunitinib and its primary metabolite (SU12662) in metastatic colorectal cancer patients.
Int J Clin Pharmacol Ther
; 49(1): 88-90, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21176741
3.
A preliminary report of a Phase II study of folinic acid, 5-fluorouracil, irinotecan (FOLFIRI) plus sunitinib with toxicity, efficacy, pharmacokinetics, biomarker, imaging data in patients with colorectal cancer with liver metastases as 1st line treatment.
Int J Clin Pharmacol Ther
; 49(1): 96-8, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21176744
4.
Pharmacokinetic/pharmacodynamic modeling of biomarker response to sunitinib in healthy volunteers.
Clin Pharmacol Ther
; 87(5): 601-8, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20376000
Resultados
1 -
4
de 4
1
Próxima >
>>